|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
*
From the Department of Pediatrics, Cook County Children's Hospital (Dr. Moy), the Department of Immunology/Microbiology (Dr. Grant), and the Center for Health Services Research, Rush Primary Care Institute (Ms. Turner-Roan, Drs. Li, and Weiss), Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL.
See Appendix for other members of the CASI Project Team.
Correspondence to: Kevin B. Weiss, MD, Center for Health Services Research, Rush Primary Care Institute, Rush-Presbyterian-St. Luke's Medical Center, 1653 W Congress Pkwy, Chicago, IL 60612
| Abstract |
|---|
|
|
|---|
Results: A total of 113 eligible
surveys were returned (response rate, 72.0%). Ninety-nine percent of
the respondents indicated they would prescribe inhaled corticosteroids
for patients
5 years old with moderate persistent asthma, and
85.5% would prescribe them for patients < 5 years old. The
respondents reported that 71.2% of their patients with moderate or
severe persistent asthma were routinely given written treatment plans.
The use of these plans was reported more frequently by allergists than
pulmonologists (77.6% vs 58.9%, p = 0.01). Nearly half of the
respondents were involved in the development of hospital-based asthma
programs; fewer (14.9%) were involved in developing asthma programs
for managed care organizations. A majority (63.4%) of the physicians
had given a formal professional education presentation on asthma in the
past year. A majority of the respondents who care for patients under
managed care contracts reported that these patients have encountered
barriers to access in seeking specialty care.
Conclusion: The results suggest that asthma specialists in the Chicago area are providing asthma care that is, in many ways, consistent with national guidelines. However, there are also important differences in care that are not consistent with the guideline recommendations. Perhaps even more notable are differences in reported asthma care between the two subspecialty groups of allergists and pulmonologists. The effect of these differences on the management of persons with asthma is not known. It is hoped that information from this community-based survey will serve to catalyze discussions among Chicago-area asthma specialists as to how they might envision improving care for persons with asthma in their community.
| Introduction |
|---|
|
|
|---|
Asthma is one of the common chronic conditions for which there has been substantive subspecialty input into nationally accepted clinical practice guidelines. Asthma subspecialists were instrumental in both the design and dissemination of the expert panel report, "Guidelines for the Diagnosis and Management of Asthma," of the National Asthma Education and Prevention Program (NAEPP), first published in 19911 and subsequently revised in 1997.2 However, to date, few studies have closely explored how well physicians who consider themselves specialists in asthma care adhere to these guidelines.3 4 5 6 7 None of these studies examine the similarities or differences in reported care between the two different subspecialties of allergy and pulmonology. Yet collectively, these two groups constitute nearly all physicians who are commonly considered to be asthma specialists.
Chicago has one of the highest asthma mortality rates in the nation.8 It has been suggested that quality of and access to health care are key factors relating to this disproportionate mortality. Therefore, within the Chicago community, there is a large concern over the quality of care provided by its physicians. The purpose of this study was to characterize the current knowledge, attitudes, beliefs, and self-reported practices of asthma specialistsboth allergists and pulmonologistsworking in the Chicago metropolitan area. A secondary purpose was to examine differences between allergists and pulmonologists for several key aspects of asthma care.
| Materials and Methods |
|---|
|
|
|---|
Study Population
Chicago-area asthma specialists were identified from the
American Medical Association (AMA) 1995 Masterfile,9
which
contains names and professional information on all practicing
physicians in the United States. Physicians meeting the following
criteria were identified: (1) engaged in direct patient care; (2)
practice location in Cook, Lake, Du Page, McHenry, Kane, or Will
counties, IL; and (3) primary or secondary specialty of allergy,
allergy and immunology, allergy and immunology/diagnostic laboratory
immunology, pulmonary diseases, critical care medicine, or pediatric
pulmonology.
Survey Instrument
A self-administered survey instrument was constructed on the
basis of existing surveys developed by the National Heart, Lung, and
Blood Institute,4
the Quality Assurance Reform
Initiative project of the National Committee on Quality
Assurance,10
and the Managed Health Care
Association.11
An advisory panel of local allergists and pulmonologists reviewed the survey items and content areas. The survey was revised on the basis of panel recommendations to include additional questions reflecting new content areas. The final survey instrument consisted of 174 items covering the following content areas of asthma care: (1) diagnosis; (2) clinical monitoring; (3) pharmacologic and nonpharmacologic treatment; (4) opinions and beliefs about treatment options and reasons for referrals; (5) involvement in continuing medical education; (6) experiences with managed care; (7) use of asthma practice guidelines; (8) respondent demographics; and (9) characteristics of practice settings.
Sampling Methods
From the AMA Masterfile, 364 specialty physicians were
identified. The 364 listings were subsequently sorted into one of three
groups: group 1 consisted of 244 physicians with a primary specialty of
allergy, pulmonology, pediatric pulmonology, or critical care medicine;
group 2 consisted of 109 physicians with a secondary specialty of
allergy, pulmonology, pediatric pulmonology, or critical care medicine;
and group 3 consisted of 11 physicians with a combination of either
allergy, pulmonology, pediatric pulmonology, and critical care medicine
as their primary and secondary specialty. The survey sample included
all 11 physicians in group 3 and 50% of the physicians in groups 1 and
2. Physicians were considered ineligible if they had retired, were
deceased, or had moved their practice outside of the six-county study
area.
Survey Administration
The survey was mailed to the sample population along with a
cover letter and a postage-paid return envelope. The physicians were
asked to return their surveys by mail or fax. To maximize the response
rate, the first mailing was supplemented by additional mailings and
telephone calls to nonrespondents.
Data Analysis
Completed surveys were excluded from this
analysis if the respondent reported that asthma patients constitute
< 1% of their practice. For the survey items that inquired about
care for children < 5 years old, responses from physicians who did
not provide care for patients in that age group were also excluded from
the analysis.
For the comparisons between pulmonologists and allergists, the
respondents were classified by specialty on the basis of their response
to the question, "How would you best describe your current medical
specialty?" Respondents were also asked whether they were Board
certified or eligible in each specialty. Those that reported Board
certification or eligibility in pulmonary medicine or pediatric
pulmonary medicine were classified as pulmonologists. Those that
reported Board certification or eligibility in allergy and clinical
immunology were classified as allergists. Data analysis was conducted
using SAS computer software (SAS Version 6.12; SAS Institute; Cary,
NC). When appropriate, tests of significance were performed using
2 or nonparametric analysis of variance. Means
are reported with SE.
For the purposes of this discussion, the term "very few" is used to describe responses reported by < 20% of the respondents, "minority" refers to 20 to 49%, "majority" refers to 50 to 79%, and "nearly all" refers to 80 to 100%.
This project was approved by the Institutional Review Board of Rush-Presbyterian-St. Luke's Medical Center.
| Results |
|---|
|
|
|---|
General Characteristics of Physicians and Practices
Table 1
displays some of the demographic characteristics of the respondents in
comparison to the other Chicago-area pulmonologists and allergists in
the 1995 AMA Masterfile. The sample respondents were similar to the
other Chicago-area asthma specialists by specialty distribution, age,
sex, years since graduation, United States graduation, and type of
practice setting.
|
The respondents estimated that patients with asthma represented an average of 46.5 ± 2.4% of their practice, with allergists reporting slightly higher percentages than pulmonologists (49.0 ± 0.03% vs 40.0 ± 0.04%, respectively; p = 0.08).
Approach to Evaluation and Monitoring of Asthma Patients
The survey examined the respondents' opinions regarding what
percent of patients with newly diagnosed moderate persistent asthma
should receive certain diagnostic tests. As seen in Table 2
, spirometry was recommended for nearly all patients. The respondents
reported that the majority of asthma patients should receive a trial of
daily peak flow monitoring, a chest radiograph, and testing for
IgE-mediated allergies and that very few patients should require a
sputum examination and staining for eosinophilia.
|
Table 2 also displays the responses to questions asked about other diagnostic tests for patients with moderate or severe persistent asthma. The specialists reported that, with the exception of the nasal speculum examination, few tests other than those noted above were routinely obtained. When asked about radiographic evaluation of the sinuses, 11.9% of the physicians reported that they routinely ordered CT scans and 4.0% routinely ordered sinus radiographs (p = 0.04). None of the respondents ordered an MRI of the sinuses as part of their routine examination of persons with moderate or severe asthma.
For patients with moderate persistent asthma under good control, 73.3% of the respondents reported scheduling routine visits more frequently than every 6 months; 13.9% indicated they scheduled routine visits less frequently than every 6 months. Very few (7.9%) of the physicians reported that they followed up with office visits only when the patient is symptomatic.
Use of Objective Airway Function Testing
The survey also queried the specialists' opinions on the
usefulness of peak flow measurements. As seen in Table 2
, the majority
of the respondents indicated that home peak flow monitoring is often
useful for patients with moderate-to-severe persistent asthma. On
average, the respondents also indicated that the majority of their
patients with moderate-to-severe asthma are instructed to monitor peak
flow readings at home. In comparing the two types of asthma
specialists, the allergists' patients were more likely to have been
prescribed home peak flow monitoring than the pulmonologists' patients
(79.5 ± 4.2% vs 52.6 ± 5.8%; p < 0.01). The allergists and
pulmonologists also differed in their use of objective testing of
airway function during an office visit. Overall, 75.0% of the
respondents reported performing peak flow measurements or pulmonary
function testing "often" for acutely symptomatic patients; by
specialty, 84.5% of allergists vs 57.9% of pulmonologists performed
these tests "often" (p < 0.01). As for asymptomatic patients,
51.0% of the respondents reported performing these tests "often"
during an office visit, and, similar to the acute patient scenario,
reported use was higher for allergists than pulmonologists (60.3% vs
34.2%; p = 0.01).
Nearly all (85.3%) the respondents reported that they had a spirometer in their offices, whereas very few (14.9%) reported referring their patients for pulmonary function testing at another hospital, clinic, or asthma specialist.
Medications
Several of the survey items asked about the types of medications
prescribed for patients with mild intermittent, moderate persistent,
and severe persistent asthma.
Medications Prescribed for Mild Intermittent Asthma:For patients < 5 years old with mild intermittent asthma, nearly
all (94.7%) the specialists reported that they were likely to
prescribe inhaled ß-agonists, and the majority (61.4%) were likely
to prescribe cromolyn or nedocromil. Prescription of oral ß-agonists
(45.6%) and inhaled corticosteroids (30.9%) were reported less
frequently. Very few specialists (12.5%) were likely to prescribe
theophylline. For patients
5 years with mild intermittent asthma,
the responses were similar to the younger patients. There were no
significant differences in treatment by specialist type for patients
with mild intermittent asthma.
Medications for Moderate Persistent Asthma:Table 3
characterizes the use of pharmacologic agents in the treatment of
persons with moderate persistent asthma. The survey data show that
100% of the respondents were likely to prescribe inhaled ß-agonists
for patients with moderate or severe persistent asthma. The respondents
were more likely to prescribe oral ß-agonists for patients < 5
years of age (36.4%) than for patients
5 years (21.5%;
p = 0.05). Ninety-nine percent of the respondents indicated they
would prescribe inhaled corticosteroids for patients
5 years of age
with moderate persistent asthma and 85.5% would prescribe them for
patients < 5 years. Forty-five percent of the respondents reported
that they were likely to prescribe theophylline for patients
5
years of age, whereas 33.3% were likely to prescribe it for patients
< 5 years of age.
|
5 years (60.3% of the allergists vs 38.2% of the
pulmonologists; p = 0.04). For children < 5 years of age, 83.9% of
the respondents were likely to prescribe cromolyn or nedocromil. Medications Prescribed for Severe Persistent Asthma: For children < 5 years of age with severe persistent asthma, the respondents were most likely to prescribe inhaled ß-agonists (100.0%), followed by inhaled corticosteroids (98.2%), systemic corticosteroids (89.1%), and cromolyn or nedocromil (69.1%). A minority of the respondents were likely to prescribe theophylline (55.4%) and oral ß-agonists (43.4%).
For patients
5 years of age with severe persistent asthma, the
responses were similar to those for the younger patients, with the
exceptions that only 48.9% of the physicians reported that they were
likely to prescribe cromolyn or nedocromil, but 76.3% were likely to
prescribe theophylline. When comparing allergists and pulmonologists,
there was only one marginal difference in medication choice for
patients with severe persistent asthma. For patients < 5 years with
severe persistent asthma, 57.1% of the allergists indicated they would
prescribe theophylline, whereas none of the pulmonologists chose
theophylline for this age group (p = 0.05).
When asked the question, "For a patient (
5 years) with daily
symptoms that respond to three times per day short-acting inhaled
ß-agonists as his or her only medication who is waking up more than
twice a month with asthma symptoms, what would you do next?" 82.2%
of the respondents indicated they would add inhaled anti-inflammatory
medications (72.3% specified inhaled corticosteroids and 9.9%
specified cromolyn or nedocromil). Nearly 10% of the respondents
reported that they would add a long-acting ß-agonist instead of
anti-inflammatory medications. There were no significant differences in
responses between the allergists and pulmonologists with regard to this
question.
Perceptions of the Safety of Inhaled Corticosteroids
When asked about the safety of long-term use of inhaled
corticosteroids at standard doses, the majority (57.0%) of the
respondents answered "very safe." A minority (41.0%) answered
"safe," and 2.0% were "uncertain." For patients < 5 years, a
minority of the respondents perceived their use as "very safe"
(31.8%) or "safe" (44.7%). Approximately 21% of the respondents
were unsure of the safety, and 2.4% answered "unsafe."
Nonpharmacologic Management of Asthma
Sixty-six percent of the physicians (98.3% of the allergists and
15.8% of the pulmonologists; p < 0.001) reported using
immunotherapy for patients with moderate asthma. On average, these
physicians used immunotherapy on 38.0 ± 3.2% of their patients with
moderate asthma.
For all respondents, the most commonly reported environmental control measures recommended for patients with stable moderate or severe asthma were avoidance of household tobacco smoke (97.0%) and removal of pets from the bedroom (87.0%). Recommended use of mattress and pillow covers was reported by 68.3% of the respondents. Only a minority routinely recommended high-efficiency particulate air filters (35.6%) or dehumidification. Routine cleaning of ductwork and avoidance of exercise and physical activity were recommended rarely.
Approach to Asthma Education
Regarding asthma patient education, only 11.0% of the respondents
reported that they referred their patients to a formal asthma education
program. Instead, 87.1% reported that they conducted informal
educational programs in their offices. One fourth of the physicians
reported that their practices had a dedicated asthma case manager for
patients with difficult-to-control asthma. Of the case managers, 66.7%
were reported to be registered nurses. Nineteen percent of the
physicians reported that their practice had a dedicated nonphysician
health educator who delivered formal asthma education. Of the health
educators, 65.0% were reported to be registered nurses.
Opinions About Referrals to Asthma Specialists
The specialists were asked the question, "which of the following
should prompt a primary care physician to refer patients to an asthma
specialist?" Nearly all reported that the following should prompt a
consultation: a life threatening episode (100.0%), severe persistent
asthma (99.0%), continued symptoms on multiple medications (99.0%),
hospitalization for asthma (92.1%), and diagnosis in children
3
years (84.6%). Most of the specialists (59.4%) reported that an
emergency department visit was an indication for consultation, and
29.7% viewed a diagnosis of mild persistent asthma as a reason for
consultation.
Other Aspects of Asthma Management
When asked about asthma practice guidelines, very few of the
physicians responded that they did not follow any type of asthma
practice guidelines (Table 4
). Of the various types of asthma guidelines available, 89.0% of the
respondents indicated that they followed the NAEPP guidelines.
|
All of the physicians indicated that patients had 24-h telephone access to their practice. The specialists were asked what they would do if a patient called for an acute but nonlife-threatening asthma exacerbation. Sixty-eight percent of the asthma specialists reported that they would provide a same-day appointment at the office, and very few reported they would instruct the patient to go to the emergency department (14.0%).
Managed Care Issues
Ninety-two percent of the respondents reported that managed care
patients were a part of their practices. As seen in Figure 1 , a majority of the respondents indicated that their patients with
managed care coverage have encountered barriers to access in seeking
specialty care. More than half of the physicians reported being
contacted by either a managed care organization or pharmaceutical
benefits manager about their prescribing practices for asthma patients.
Figure 1
also shows that significantly more allergists than
pulmonologists answered yes to both of these questions.
|
| Discussion |
|---|
|
|
|---|
However, the survey data also demonstrate important differences in specialists' care vs the NAEPP guideline recommendations. For example, although the survey data indicate overall frequent use of peak flow or spirometry for monitoring patients, there was a clear tendency for the specialists to use these tools much more commonly for acutely symptomatic patients than for asymptomatic patients. The specialists also reported moderate use of inhaled steroids for patients with mild intermittent asthma. These routine asthma care practice patterns, although inconsistent with guideline recommendations, do not, in and of themselves, suggest poor clinical care. Rather, they present issues for further discussion on what might be considered normative specialty care.
The inconsistencies in asthma care between the specialist groups also
have the potential to deliver confusing messages to primary-care
physicians and their patients. Some of these differences, such as
higher use of immunotherapy by allergists, are not surprising. However,
differences in the use of diagnostic imaging (eg, chest and
sinus radiographs) and testing for allergen sensitivity (either by skin
prick or radioallergosorbent test) are of greater concern. Although the
increased use of chest radiographs by pulmonologists may reflect an
older patient population with more comorbidity, the differences in
other aspects of care are less easily explained. Allergists were more
likely than pulmonologists to encourage the use of peak flowmeters and
to provide written treatment plans for their patients. The two
subspecialties also appear to differ in their pharmacotherapeutic
approaches to asthma, particularly in the use of cromolyn or nedocromil
and inhaled steroids for patients
5 years with moderate persistent
asthma. The effect of these differences in the management of persons
with asthma is not known.
The physicians in these two subspecialties appear to represent key leadership in professional education about asthma. Nearly half of the sampled asthma specialists had participated in the development of hospital-based asthma programs, and almost two thirds had given a formal talk or presentation on asthma during the past year. However, the selected practice differences in asthma care between these two specialty groups could potentially confuse the key messages about asthma care that are sent out to the Chicago community. It is also not known how well the asthma specialists in this community are serving in the role of local professional educators of appropriate asthma care.12
As for managed care, nearly three quarters of the specialists reported that their patients experienced barriers in obtaining a referral from their managed care organization. It has been well argued that appropriate access to specialty care is essential to achieve optimal clinical outcomes for many health conditions.13 For asthma, many studies suggest that outcomes are improved with appropriate access to specialty care.3 6 7 14 15 The high frequency of barriers to asthma specialists reported in this survey highlights an issue of community concern. Addressing and solving this concern could lead to community-wide asthma improvements.
Several limitations of this study should be noted. As with any
self-reported data, respondents may have reported what they believe to
be acceptable, instead of their actual practice. The age of the
patients treated may also affect some aspects of care. The number of
pediatric pulmonologists in the sample (and in the AMA Masterfile) was
small; therefore, it is likely that, as a group, the pulmonologists in
the sample treat older patients than the allergists. For this reason,
in data analysis of items that were specific for children < 5 years,
respondents were excluded if they indicated they did not see children
in that age group. The items used in the questionnaire did not
distinguish between care for children
5 years and care for adults.
However, for many aspects of asthma care (eg, use of peak
flow measurements, spirometry, written treatment plans, and allergy
evaluation) the NAEPP guidelines also do not distinguish
recommendations between older children and adults. Lastly, it should be
recognized that the asthma care delivered by Chicago-area specialists
is not necessarily reflective of specialty care in other communities or
geographic areas.
There are also some key strengths to this community-based survey of self-reported care to counterbalance the limitations of this report. Although the information gained from this survey may not be generalizable nationwide, it does represent the views of caregivers of a United States community of > 8 million persons and > 300 asthma specialists. In this respect, the survey results provide a baseline from which specialists can begin to explore asthma care issues of local and perhaps regional or national interest. The data could also be used as a benchmark for similar studies in other communities.
| Conclusion |
|---|
|
|
|---|
| Appendix 1 |
|---|
|
|
|---|
| Acknowledgements |
|---|
| Footnotes |
|---|
Abbreviations: AMA = American Medical Association; CASI = Chicago Asthma Surveillance Initiative; NAEPP = National Asthma Education and Prevention Program
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. A. Finkelstein, P. Lozano, R. Shulruff, T. S. Inui, S. B. Soumerai, M. Ng, and K. B. Weiss Self-Reported Physician Practices for Children With Asthma: Are National Guidelines Followed? Pediatrics, October 1, 2000; 106(4): 886 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Weiss and E. N. Grant The Chicago Asthma Surveillance Initiative: A Community-Based Approach to Understanding Asthma Care Chest, October 1, 1999; 116(suppl_2): 141S - 145S. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |